Merck & Co.

Blue race track
AI and Machine Learning

Merck grows more ambitious about 'workhorse' TROP2 ADC

Merck has already registered 15 global phase 3 trials for its Kelun-partnered TROP2 antibody-drug conjugate, sac-TMT.
Angus Liuu Oct 20, 2025 4:00pm
Merck Co headquarters

ESMO: Merck lays out Keytruda's landmark win in ovarian cancer

Oct 18, 2025 10:30am
On target clinical trial success bullseye score

Keytruda, Padcev cut risk of death by 50% in MIBC patient subset

Oct 18, 2025 10:30am
merck

In ovarian cancer, Keytruda follows PFS win with survival showing

Oct 16, 2025 10:23am
cardboard box with office belongings and a desk chair
Favicon Fierce Biotech

Big pharma cuts and gene therapy woes: Inside Q3's layoffs

Oct 3, 2025 4:30pm
Moderna

Moderna crowns new UK facility as other pharmas pile on Britain

Sep 25, 2025 9:55am